U S Physical Therapy Inc (USPH) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
U S Physical Therapy Inc  (NYSE: USPH)


U S Physical Therapy Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is U S Physical Therapy Inc's ROI in the second quarter of 2026?
U S Physical Therapy Inc achieved a return on average invested assets (ROI) of 4.4 % in its second quarter of 2026, which is below U S Physical Therapy Inc's average return on investment, which stands at 9.08%.

ROI fell compared to the first quarter of 2026, despite the net income growth of 82.66% from the first quarter of 2026.

Within the Healthcare sector 150 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 1672 to 1710.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM 8.98 % 13.14 % 16.66 % 21.47 % 15.21 %
Y / Y Net Income Change TTM -6.71 % 11.05 % 70.69 % 185.37 % 356.45 %
Investment (TTM) in Millions 1,139 1,168 1,107 1,123 1,102
Return On Investment (TTM) 4.4 % 4.68 % 5.24 % 5.61 % 5.14 %
USPH's Overall Ranking # 1710 # 1672 # 1236 # 1283 # 1228
Seq. Investment Change TTM 0.83 % 1.62 % 1.28 % 5.03 % 4.67 %
Seq. Net Income Change TTM -5.36 % -9.16 % -5.41 % 14.71 % 12.66 %
Net Income (TTM) in Millions 50 53 58 61 53

USPH Company Profile >> Back to USPH Roi Comparisons >> See Annual USPH Return On Investment



Return On Investment USPH's Ranking
Within: No.
Industry # 49
Sector # 151
Overall # 1710

Return On Investment Statistics
High Average Low
18.99 %
9.08 %
3.17 %
(Sep 30 2012)   (Sep 30 2024)







Financial Statements
U S Physical Therapy Inc's II. Quarter Investments $ 1,139 Millions USPH's Balance sheet
U S Physical Therapy Inc's II. Quarter Income $ 15 Millions Quarterly USPH's Income Statement
USPH's Income by Division See USPH's Income by Division


USPH Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 1,065 1,051 855 773 666
Y / Y Investment Growth 1.31 % 23.01 % 10.6 % 16.03 % 42.94 %
Net Income in Millions 58 46 37 43 58
Y / Y Net Income Growth 27.2 % 22.51 % -14.25 % -25.06 % 10.35 %
Annual Return On Investment 5.45 % 4.34 % 4.36 % 5.62 % 8.7 %


Annual Roi Comment
In the fiscal year 2025 ROI improved to 5.45 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
USPH's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for USPH's Competitors
Subscribers only: Roi for U S Physical Therapy Inc's Suppliers
Subscribers only: Return On Investment for USPH's Customers

Other Ratios
USPH's Roa USPH's Inventory Turnover Ratio USPH's Growth Rates USPH's Dividend Statistics
USPH's Profitability Ratios USPH's Asset Turnover Ratio USPH's Dividend Growth
USPH's Roe USPH's Valuation Ratios USPH's Financial Strength Ratios USPH's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI
Solventum Corporation  11.98 %
Ligand Pharmaceuticals Incorporated  11.93 %
Lifevantage Corp  11.84 %
Regeneron Pharmaceuticals Inc   11.83 %
Protagonist Therapeutics inc   11.66 %
Encompass Health Corporation  11.56 %
Embecta Corp   11.20 %
Lemaitre Vascular Inc   11.20 %
3m Company  11.16 %
Globus Medical Inc   11.01 %
National Healthcare Corp  10.91 %
Bioventus Inc   10.85 %
Infusystem Holdings Inc  10.53 %
Livanova Plc  10.40 %
Beone Medicines Ltd   10.32 %
Entrada Therapeutics Inc   10.15 %
Jazz Pharmaceuticals Plc  10.06 %
Prestige Consumer Healthcare Inc   10.06 %
Tactile Systems Technology Inc   10.02 %
Tenet Healthcare Corp  9.98 %
Nature s Sunshine Products inc   9.91 %
Boston Scientific Corporation  9.91 %
Align Technology inc   9.50 %
Pediatrix Medical Group Inc   9.18 %
Abbvie Inc   9.11 %
Ani Pharmaceuticals Inc  9.09 %
Viemed Healthcare Inc   8.97 %
Stryker Corp  8.80 %
Penumbra Inc  8.71 %
Utah Medical Products Inc  8.70 %

Date modified: 2026-09-26T07:12:56+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.